SuperworthExponent EPS EXPO
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jul 3, 2026
- $2.23
- Latest quarter, Q2 FY26
- $0.60
- +15% on a year earlier
- Fiscal year 2025
- $2.08
- −2% on the year before
Exponent's earnings per share was $2.23 over the twelve months to Jul 3, 2026, up 12% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.60, up 15% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 6% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $2.08 | −2% |
| FY2024 | $2.12 | +9% |
| FY2023 | $1.95 | −1% |
| FY2022 | $1.96 | +3% |
| FY2021 | $1.90 | +23% |
| FY2020 | $1.55 | +1% |
| FY2019 | $1.53 | +14% |
| FY2018 | $1.34 | +74% |
| FY2017 | $0.77 | −12% |
| FY2016 | $0.88 | +9% |
| FY2015 | $0.80 | +8% |
| FY2014 | $0.74 | +8% |
| FY2013 | $0.69 | +5% |
| FY2012 | $0.65 | +18% |
| FY2011 | $0.56 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.60 | +15% | $2.23 | |
| Q1 FY26 | $0.59 | +13% | $2.15 | |
| Q4 FY25 | $0.49 | +7% | $2.08 | |
| Q3 FY25 | $0.55 | +10% | $2.05 | |
| Q2 FY25 | $0.52 | −9% | $2.00 | |
| Q1 FY25 | $0.52 | −12% | $2.05 | |
| Q4 FY24 | $0.46 | +12% | $2.12 | |
| Q3 FY24 | $0.50 | +4% | $2.07 | |
| Q2 FY24 | $0.57 | +14% | $2.05 | |
| Q1 FY24 | $0.59 | +5% | $1.98 | |
| Q4 FY23 | $0.41 | −7% | $1.95 | |
| Q3 FY23 | $0.48 | +2% | $1.98 |
Against its peers
Companies in Consulting Services nearest Exponent's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| EXPOExponent | $2.23 | +12% a year |
| FCNFTI Consulting | $8.27 | +16% a year |
| HURNHuron Consulting | $6.67 | +16% a year |
| ASTHAstrana Health | $0.82 | +61% a year |
| GGenpact LTD | $3.37 | +12% a year |
| ICFIICF International | $4.83 | −16% a year |
| BAHBooz Allen Hamilton | $6.38 | −22% a year |
| BWMNBowman Consulting | $0.40 | −34% a year |
| EFXEquifax | $5.69 | +11% a year |
| Peer median | $5.26 |
Where Exponent ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Exponent
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.